Search Within

Sergio Andres Giralt

Formats
  1. Meeting Abstract (642)
  2. Journal Article (376)
  3. Research Letter (20)
  4. Review (15)
  5. Guidelines (5)
  6. Correspondence (4)
  7. Editorial (4)
  8. Book Section (3)
Groups
  1. Bone Marrow Transplant (1069)
  2. Center for Hematologic Malignancies (1069)
  3. Department of Medicine (1069)
  4. Hematologic Malignancies, Division of (1069)
  5. Survivorship Research (703)
  6. CTCR Scholars (557)

More Groups

People
  1. Miguel-Angel Perales (429)
  2. Sean Devlin (380)
  3. Gunjan Shah (311)
  4. Michael Scordo (279)
  5. Heather Landau (263)
  6. Ann Jakubowski (242)

More People

Years
  1. 2025 (18)
  2. 2024 (65)
  3. 2023 (104)
  4. 2022 (77)
  5. 2021 (66)
  6. 2020 (91)

More Years

Publications
  1. Blood (314)
  2. Biology of Blood and Marrow Transplantation (275)
  3. Bone Marrow Transplantation (80)
  4. Clinical Lymphoma, Myeloma and Leukemia (60)
  5. Journal of Clinical Oncology (40)
  6. Transplantation and Cellular Therapy (36)

More Publications

Publishers
  1. Elsevier Inc. (386)
  2. American Society of Hematology (349)
  3. Nature Publishing Group (110)
  4. American Society of Clinical Oncology (42)
  5. Taylor & Francis Group (35)
  6. Ferrata Storti Foundation (13)

More Publishers

Results (1069)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical impact of bridging therapy prior to commercial chimeric antigen receptor (CAR) T-cell therapies for relapsed/refractory lymphomas
    Meeting Abstract

    Imber, B. S.; Perales, M. A.; Flynn, J.; Ruiz, J. D.; Devlin, S.; Alarcon Tomas, A.; Hajj, C.; Batlevi, C. L.; Dahi, P. B.; Lin, R. J.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • High doses of targeted radiation with anti-CD45 iodine ((131)I) apamistamab [Iomab-B] do not correlate with incidence of mucositis, febrile neutropenia or sepsis in the prospective, randomized phase 3 SIERRA trial for patients with relapsed or refractory acute myeloid leukemia
    Meeting Abstract

    Gyurkocza, B.; Nath, R.; Choe, H.; Seropian, S.; Stiff, P. J.; Abhyankar, S.; Agura, E.; Litzow, M.; Tomlinson, B. K.; Chen, G. L.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Personalized targeted radioimmunotherapy with anti-CD45 iodine ((131)I) apamistamab [Iomab-B] in patients with active relapsed or refractory acute myeloid leukemia results in successful donor hematopoietic cells engraftment with the timing of engraftment not related to the radiation dose delivered
    Meeting Abstract

    Gyurkocza, B.; Nath, R.; Choe, H.; Seropian, S.; Stiff, P. J.; Abhyankar, S.; Agura, E.; Litzow, M.; Tomlinson, B. K.; Chen, G. L.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Long-term sustained minimal residual disease (MRD) negativity in patients with multiple myeloma treated with continuous lenalidomide maintenance therapy: A clinical and correlative phase 2 study
    Meeting Abstract

    Diamond, B.; Korde, N.; Lesokhin, A. M.; Smith, E. L.; Shah, U. A.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Tan, C.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • KarMMa-3: A phase 3 study of idecabtagene vicleucel (ide-cel, bb2121), a BCMA-directed CAR T cell therapy vs standard regimens in relapsed and refractory multiple myeloma
    Meeting Abstract

    Delforge, M.; Baz, R. C.; Cavo, M.; Callander, N. S.; Ghobadi, A.; Rodriguez-Otero, P.; Mateos, M. V.; Massaro, M.; Ding, L.; Patel, P.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • TCR repertoires in graft-versus-host-disease (GVHD)-target tissues reveals tissue specificity of the alloimmune response
    Meeting Abstract

    DeWolf, S.; Nichols, K.; Nguyen, C. L.; Giardina, P. A.; Slingerland, J. B.; Elias, H.; Kappangantula, R.; Baez, P.; Murali, R.; Hayashi, A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Conditioning regimen comparison for allogeneic stem cell transplantation in non-Hodgkin lymphoma
    Meeting Abstract

    Peterson, K.; Lin, A.; Ruiz, J.; Zheng, J.; Devlin, S.; Shah, G.; Scordo, M.; Sauter, C.; Perales, M.; Giralt, S.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • International prognostic index predicts outcomes in patients with relapsed and refractory large diffuse B cell lymphoma treated with commercial CAR T cells
    Meeting Abstract

    Garcia-Recio, M.; Wudhikarn, K.; Pennisi, M.; Alonso-Trillo, R.; Flynn, J.; Roni, S.; Batlevi, Y.; Silverberg, M. L.; Batlevi, C. W.; Brentjens, R.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Implications of novel risks scores (AML-DRG and AML-HCT-CR) in allogeneic CD34+ selected graft transplant outcomes
    Meeting Abstract

    Trillo, R. A.; Recio, M. G.; Pennisi, M.; Cho, C.; Devlin, S. M.; Ruiz, J. D.; Maloy, M. A.; Tomas, A. A.; Castillo, N.; Lin, R. J.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • CMV seropositivity drives T cell reconstitution after CD34-selected allogeneic HCT despite reduction of viremia with letermovir
    Meeting Abstract

    Cho, C.; Lavery, J.; Ruiz, J.; Maloy, M.; Maslak, P.; Giralt, S. A.; O'Reilly, R. J.; van den Brink, M. R. M.; Perales, M. A.
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save